2020
DOI: 10.1002/14651858.cd006359.pub3
|View full text |Cite
|
Sign up to set email alerts
|

Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes

Abstract: Editorial group: Cochrane Gynaecology and Fertility Group. Publication status and date: New search for studies and content updated (conclusions changed), published in Issue 10, 2020.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
47
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(59 citation statements)
references
References 75 publications
0
47
0
2
Order By: Relevance
“…High-quality evidence shows no consistent advantage of any endometrial preparation has been established (62,63). Moreover, A large meta-analysis study with a total of 31 RCTs (5426 women) in 2020 failed to show a definitive optimal protocol for endometrial preparation (64). However, letrozole is cheap, being patient-friendly, yielding at least equivalent pregnancy rates when compared with natural and artificial cycles with or without suppression, require less luteal support than artificial cycles.…”
Section: Letrozole In Preparation Of Endometrium For Fetmentioning
confidence: 99%
“…High-quality evidence shows no consistent advantage of any endometrial preparation has been established (62,63). Moreover, A large meta-analysis study with a total of 31 RCTs (5426 women) in 2020 failed to show a definitive optimal protocol for endometrial preparation (64). However, letrozole is cheap, being patient-friendly, yielding at least equivalent pregnancy rates when compared with natural and artificial cycles with or without suppression, require less luteal support than artificial cycles.…”
Section: Letrozole In Preparation Of Endometrium For Fetmentioning
confidence: 99%
“…There are different FET cycle regimens used to prepare the endometrium, including natural cycles, hormone replacement therapy (HRT) with estrogen and progesterone, cycles in which ovulation is induced by drugs, and gonadotrophin-releasing hormone agonist (GnRH-a) cycles. Although there are many options for the preparation of the endometrium, there is still no uniform recommendation for the preparation of the FET endometrium for different groups of women to date (6)(7)(8). For patients with abnormal ovulation in particular, there have been few studies on FET protocols; notably, most of these studies focus only on the clinical pregnancy rate or LBR (9)(10)(11) and pay little attention to the regimen's safety for offspring.…”
Section: Introductionmentioning
confidence: 99%
“…In terms of estrogens, natural as well as synthetic E 2 can be used, but again to our knowledge, no trial compared these two forms of E 2 usage in HRT cycles. Different routes, including oral (micronized estradiol or estradiol valerate), vaginal (estradiol valerate) or transdermal (estradiol gel), can be used for the administration of E 2 with comparable reproductive outcomes (5). Although vaginal E 2 may be administered in a ring, tablet or cream forms, local vaginal irritation, discomfort, and unsatisfactory absorption especially when administered together with vaginal P are the reasons why the vaginal route of E 2 administration is not the preferred route by the majority of IVF clinics (10).…”
Section: Hormone Replacement Treatment (Hrt) Estrogen Administrationmentioning
confidence: 99%
“…Despite the increase in FET, the most optimal priming protocol of the endometrium is still a matter of debate (5). The available FET protocols are i) true natural cycle (t-NC) with/ without luteal phase support (LPS) ii) modified NC (modified-NC) with/without LPS, iii) hormone replacement treatment (HRT) with or without gonadotropin releasing hormone (GnRH) analogue suppression, and iv) mild ovarian stimulation (mild-OS) using gonadotropins, clomiphene citrate (CC), or letrozole (Table 1).…”
Section: Introductionmentioning
confidence: 99%